Company profile
Neptune Wellness Solutions Inc.
OTC: NEPTF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Laval, QCCIK 0001401395Reports USD
#433 of 1,422 Healthcare companies by revenue54th-percentile growth
EA Score
——FH —DQ 13GM —SS 42
v0.1 · 25/100 weight · pillars only
↑ listing tenure, revenue growth (YoY) · ↓ market scale, disclosure history
Methodology →Revenue TTM
$39.1M
Rev growth YoY (TTM)
-26.5%
Net income (FY)
-$60.5M
Employees
50
as of 2026-07-12
Market cap
$453
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$51.7M$51.7M2023
Net income-$60.5M-$60.5M2023
Operating income-$102.8M-$102.8M2023
Total assets$30.9M$30.9M2023
Liabilities$58.5M$58.5M2023
Equity-$11.9M-$11.9M2023
Revenue trend
FY2022 – FY2023 · USD
FY22
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Neptune Wellness Solutions Inc.’s revenue?
Neptune Wellness Solutions Inc. booked $51.7M in FY2023 revenue, growing 8.5% year over year — about the middle of the pack among Healthcare companies we track, at a -116.8% net margin.
Peers · Healthcare
ONE Bio Corp.——Vext Science, Inc.64COcular Therapeutix, Inc.62CLENSAR Inc55CCipher Pharmaceuticals Inc.84B+Carlsmed, Inc.54DKey facts
CEOMichael A. de Geus
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLaval, QC
ExchangeOTC: NEPTF
Employees50
IPO date2007-08-13
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.